Literature DB >> 1380283

Prognostic factors in juvenile chronic granulocytic leukaemia.

G Owen1, I J Lewis, M Morgan, A Robinson, R F Stevens.   

Abstract

A retrospective analysis of the clinical and haematological characteristics of patients diagnosed as having juvenile chronic granulocytic leukaemia between 1971 and 1986 was carried out. Thirty-three children were identified who were between the ages of 18 weeks and 8.8 years at diagnosis. The disease was more frequent in boys than girls (23:10). The most common presenting symptoms were skin rash (58%) and bleeding manifestations (45%). All patients had some degree of splenomegaly and in 88% this was more than 3 centimetres below the costal margin. Hepatomegaly and lymphadenopathy were also frequent findings. Anaemia was common and leucocytosis an invariable finding with a white cell count above 50 x 10(9) 1-1 in 42%. Monocytosis was found in 78%. Haemoglobin F measurements were available in 31 children and above 10% in 22 (67%). No child had the Philadelphia chromosome or monosomy 7. Thirty children were treated with chemotherapy, with a variable degree of symptomatic improvement. Twenty-nine patients had died with a median survival time of 5 months. The commonest cause of death was complications of bone marrow failure and no child developed acute leukaemia. Presenting characteristics associated with a longer survival period were age less than 6 months (P = 0.02), female sex (P = 0.02), HbF less than 10% (P = 0.0004) and the absence of bleeding manifestations (P = 0.03). We conclude that the prognosis for children aged over 6 months, with a raised HbF level is very poor, and that, in the absence of possible bone marrow transplantation, consideration should be given to novel treatment approaches for these patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380283      PMCID: PMC2149650     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  25 in total

1.  GRANULOCYTIC LEUKAEMIA IN CHILDHOOD.

Authors:  R M HARDISTY; D E SPEED; M TILL
Journal:  Br J Haematol       Date:  1964-10       Impact factor: 6.998

Review 2.  Myelodysplasia.

Authors:  J M Chessells
Journal:  Baillieres Clin Haematol       Date:  1991-04

3.  Childhood myelodysplasia: suggested classification as myelodysplastic syndromes based on laboratory and clinical findings.

Authors:  J M Brandwein; D E Horsman; A C Eaves; C J Eaves; B G Massing; L D Wadsworth; P C Rogers; D K Kalousek
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

4.  The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia.

Authors:  H S Chan; Z Estrov; S S Weitzman; M H Freedman
Journal:  J Clin Oncol       Date:  1987-12       Impact factor: 44.544

5.  Neurofibromatosis and childhood leukemia.

Authors:  J L Bader; R W Miller
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

6.  Successful treatment of juvenile chronic granulocytic leukemia with marrow transplantation.

Authors:  J E Sanders; C D Buckner; P Stewart; E D Thomas
Journal:  Pediatrics       Date:  1979-01       Impact factor: 7.124

7.  Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferon.

Authors:  M Talpaz; J M Trujillo; W N Hittelman; M J Keating; J U Gutterman
Journal:  Br J Haematol       Date:  1985-08       Impact factor: 6.998

8.  Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia.

Authors:  J E Sanders; C D Buckner; E D Thomas; R Fleischer; K M Sullivan; F A Appelbaum; R Storb
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

9.  Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures.

Authors:  Z Estrov; T Grunberger; H S Chan; M H Freedman
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

10.  Treatment of juvenile chronic myeloid leukemia with sequential subcutaneous cytarabine and oral mercaptopurine.

Authors:  J S Lilleyman; J F Harrison; J A Black
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

View more
  2 in total

1.  Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia.

Authors:  Hideki Muramatsu; Hideki Makishima; Anna M Jankowska; Heather Cazzolli; Christine O'Keefe; Nao Yoshida; Yinyan Xu; Nobuhiro Nishio; Asahito Hama; Hiroshi Yagasaki; Yoshiyuki Takahashi; Koji Kato; Atsushi Manabe; Seiji Kojima; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2009-12-11       Impact factor: 22.113

Review 2.  Endobiogeny: a global approach to systems biology (part 2 of 2).

Authors:  Jean-Claude Lapraz; Kamyar M Hedayat; Patrice Pauly
Journal:  Glob Adv Health Med       Date:  2013-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.